Public Employees Retirement System of Ohio Boosts Position in ICU Medical, Incorporated (NASDAQ:ICUI)

Public Employees Retirement System of Ohio lifted its holdings in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 14.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,915 shares of the medical instruments supplier’s stock after acquiring an additional 2,850 shares during the quarter. Public Employees Retirement System of Ohio owned approximately 0.11% of ICU Medical worth $3,498,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in ICUI. Point72 Asset Management L.P. purchased a new position in ICU Medical during the 3rd quarter valued at $35,745,000. California State Teachers Retirement System lifted its position in shares of ICU Medical by 0.6% in the 3rd quarter. California State Teachers Retirement System now owns 30,726 shares of the medical instruments supplier’s stock worth $4,904,000 after purchasing an additional 170 shares during the period. State Street Corp boosted its stake in shares of ICU Medical by 11.9% during the 3rd quarter. State Street Corp now owns 508,266 shares of the medical instruments supplier’s stock valued at $81,119,000 after purchasing an additional 54,128 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its stake in shares of ICU Medical by 15.1% during the 3rd quarter. Northwestern Mutual Investment Management Company LLC now owns 5,480 shares of the medical instruments supplier’s stock valued at $875,000 after purchasing an additional 718 shares in the last quarter. Finally, Tamarack Advisers LP purchased a new position in shares of ICU Medical during the third quarter valued at about $5,586,000. Institutional investors own 91.85% of the company’s stock.

In other ICU Medical news, Director Robert S. Swinney sold 373 shares of the business’s stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $153.49, for a total transaction of $57,251.77. Following the sale, the director now owns 18,845 shares in the company, valued at approximately $2,892,519.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director George A. Lopez sold 20,000 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $184.29, for a total value of $3,685,800.00. Following the completion of the transaction, the director now directly owns 368,864 shares in the company, valued at $67,977,946.56. The disclosure for this sale can be found here. Corporate insiders own 11.40% of the company’s stock.

Shares of NASDAQ ICUI opened at $184.22 on Friday. ICU Medical, Incorporated has a 1 year low of $148.89 and a 1 year high of $259.72. The stock has a market cap of $3.83 billion, a P/E ratio of 23.89 and a beta of 0.92. The firm has a 50-day moving average of $171.96 and a 200 day moving average of $196.55.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Monday, November 11th. The medical instruments supplier reported $1.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.62 by $0.03. The business had revenue of $307.47 million for the quarter, compared to analysts’ expectations of $297.83 million. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The business’s revenue was down 6.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.85 earnings per share. On average, research analysts anticipate that ICU Medical, Incorporated will post 7.1 earnings per share for the current year.

A number of equities analysts recently issued reports on ICUI shares. TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research note on Monday, August 12th. Raymond James upped their price target on ICU Medical from $185.00 to $203.00 and gave the stock a “positive” rating in a research note on Tuesday, November 12th. Zacks Investment Research downgraded ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 14th. ValuEngine upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $242.00.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: How does a 12b-1 fee affect fund performance?

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.